Program

Program Format

	Track 1: Breaking Genomics Research and Technology
These sessions will highlight cutting-edge research in areas such as human genomic Variation, Structural Biology and evolutionary genomics, and practical implications of genomics research. Experimental and computational approaches for effectively utilizing the latest DNA sequencing technologies will be presented during concurrent sessions.

	Track 2: System Biology
The section will focus on the symbiotic interplay between biology, technology, and computation of systems biology, hot topics include " proteomics", " genomics", "metabolomics" and "Signaling Networks" etc. Also speakers will provide the new ways in applying systems biology and systems theory to medicine.

	Track 3: RNA Biology
This section is design to cover covering the latest findings about RNA science, methodology, technology, and applications. Hot topics include Chemical Biology of RNA, Emerging Methodologies for RNA Science, RNA Structure and Folding, RNAs in Diseases, Therapeutic RNAs, Small RNAs etc.

	Track 4: Genome-based Drug Discovery and Gene Therapy
This section aims to bring together both industry and academia thought about emerging genome technical progress and its application in the development of new therapeutic understanding and novel compounds. Beside the concurrent sessions will highlights cutting edge research in the fields of gene and cell therapy.

	Track 5: Human Genetics, Genome and Diseases
This section will present a significant contribution to the advancement of human genetics of common disease, also devoted to the challenges of human genome variation studies and genetic Analysis.

	Track 6: Human Genomics and Personalized Medicine
This section will explore the fundamental, translational, and clinical sciences driving the progress of human genomics and personalized medicine movement.

	Track 7: Other Omics and Applications
This section aims to provide a comprehensive view of omics, such as the Emerging Proteomics, Metagenomics, Metabolomics, Transcriptomics, and Interactomics etc. It will present the studies from bench to data analysis together with early-stage experimental researchers and its latest development.

	Track 8: Non-Human Functional Genomics and Beyond
This session included comparative and functional genomics studies of several, diverse, animal and plant, hot area covers transgenic animal, forest functional genomics, fish and insect functional genomics.


Young Scientist Forum

Day one April 25th, 2012
09:00 – 09:40 am	Opening Ceremony and Welcome Remarks
10:00 – 12:30 am	Keynote Forum Ⅰ
01:30 – 05:30 pm	Keynote Forum Ⅱ
06:00 – 08:30 pm	Welcome Banquet and Performance

Session 4-1: Genome-Based Target Selection and Drug Design Time: April 26, 2012, Thursday, 08:30- 12:10 Place: Xi‘ an, China
Chair	Call for Host
Co-Chair	Call for Co-Host
08:30-08:55	Speech Opportunity Available
08:55-09:20	Title: Large-Scale Rnai Screens Add Both Clarity and Complexity to Drosophila NF-ΚB Signaling Dr. Mika Ramet, Professor, University of Tampere, Finland
09:20-09:45	Title: Inhibiting HIV-1 Integrase and HIV-Infectivity by Peptides Derived from the Viral Integrase and Rev Proteins Dr. Abraham Loyter, Professor, The Hebrew University of Jerusalem, Israel
09:45-10:10	*Title:*TBD *Dr. Wim Vanden Berghe,* Scientific Staff Member, Ghent University, Belgium
10:10-10:30
10:30-10:55	Title:TBD Dr. Glenn Hicks, Academic Administrator &Associate Research Plant Cell Biologist, University of California, USA
10:55-11:20	Title:TBD Dr. Ryuichi Morishita, Professor and Chairman, Osaka University, Japan
11:20-11:45	Speech Opportunity Available
11:45-12:10	Title: Antibiotic Discovery Targeting Microbial Cell-Cell Interactions Dr. Kangmin Duan, Assistant Professor, Department of Oral Biology, Department of Medical Microbiology and Infectious Diseases, University of Manitoba, USA

Session 4-2: Gene Expression Microarrays in Drug Discovery Time: April 26, 2012, Thursday, 08:30- 12:10 Place: Xi‘ an, China
Chair	Call for Host
Co-Chair	Call for Co-Host
08:30-08:55	Speech Opportunity Available
08:55-09:20	*Title:* Marrow as a Preferencial Site to Develop Chemoresistance: Preliminary Data on Acute Myeloid Leukemia *Dr. Giuseppe Milone,* UNIT Director, University of Catania, Italy
09:20-09:45	Title: TBD Dr. Michael B Mathews, Professor and Chair, UMDNJ-New Jersey Medical School, USA
09:45-10:10	Title: Chemical Genetic Approach to Study Gene Functions in the Brain Dr. Yinghe Hu, Professor, East China Normal University, China
10:10-10:30	Coffee Break

Session 4-3: Genomic Biomarkers for Drug Discovery Time: April 26, 2012, Thursday, 13:30-17:10 Place: Xi’ an, China
Chair	*Call for Host*
Co-Chair	Call for Co-Host
13:30-13:55	Speech Opportunity Available
13:55-14:20	Title: FDA-led Efforts Toward Best Practices for the Development of Genomic Biomarkers Dr. Leming Shi, Senior Investigator, National Center for Toxicological Research U.S. Food and Drug Administration, USA
14:20-14:45	Title: TBD Dr.James Adjaye, Group Leader of the molecular embryology and aging, Max Planck Institute for Molecular Genetics, Germany
14:45-15:10	Title: Unravelling Disease Through the Integration of NGS Driven Genetics, Epigenetics and Transcriptomics Dr. Elia Stupka, Co-Director, Center for Translational Genomics and Bioinformatics, San Raffaele Scientific Institute, Italy
15:10-15:30	Coffee Break

Session 4-4: Toxicogenomics in Predictive Toxicology of IND Time: April 26, 2012, Thursday, 13:30-17:10 Place: Xi’ an, China
Chair	Call for Host
Co-Chair	Call for Co-Host
13:30-13:55	Speech Opportunity Available
13:55-14:20	Title: TBD Dr. Gordana Apic, CEO, Cambridge Cell Networks Ltd, Germany
14:20-14:45	Title: Application of Reporter Gene-Based Cellular Biosensors for Detection of Unexpected Bioactivities Dr. Lukasz Pulaski, Group Leader, Laboratory of Transcriptional Regulation, Institute of Medical Biology PAS, Poland
14:45-15:10	Title: TBD Dr. Nan Mei, Division of Genetic and Molecular Toxicology, National Center for Toxicological Research (NCTR), U.S. Food and Drug Administration (FDA), USA
15:10-15:30	Coffee Break

Session 4-5: Proteomics in Drug Discovery Time: April 27, 2012, Friday, 08:30- 12:10 Place: Xi‘ an, China
Chair	Call for Host
Co-Chair	Call for Co-Host
08:30-08:55	*Speech Opportunity Available*
08:55-09:20	*Speech Opportunity Available*
09:20-09:45	Title: TBD Dr. Goran Bergstrom, Professor, University of Gothenburg, Sweden
09:45-10:10	Title: TBD Dr. Manfred Raida, Group Leader, Mass Spectrometry, Experimental Therapeutics Centre, Singapore
10:10-10:30	Coffee Break

Session 4-6: Genomics in Anticancer Drug Discovery Time: April 27, 2012, Friday, 08:30- 12:10 Place: Xi‘ an, China
Chair	Dr. Robert Kirken, Professor and Chair, University of Texas, USA
Co-Chair	Dr. Tao Xie, Principle Scientist, Oncology Research Unit, Pfizer Inc., USA
08:30-08:55	Speech Opportunity Available
08:55-09:20	*Title:* TBD Dr. Robert Kirken, Professor and Chair, University of Texas, USA
09:20-09:45	Title: A Comprehensive Characterization of Genome-Wide DNA Copy Number Aberrations in Colorectal Tumors for Cancer Target Discovery Dr. Tao Xie, Principle Scientist, Oncology Research Unit, Pfizer Inc., USA
09:45-10:10	Title: TBD Dr. Jin-Ming Yang, Professor, The Pennsylvania State University College of Medicine and Milton S. Hershey Medical Center, USA
10:10-10:30	Coffee Break

Session 4-7: Application of RNAi to Drug Discovery Time: April 27, 2012, Friday, 13:30-17:10 Place: Xi’ an, China
Chair	Call for Host
Co-Chair	Call for Co-Host
13:30-13:55	Speech Opportunity Available
13:55-14:20	Speech Opportunity Available
14:20-14:45	Title:TBD Dr. Yasuhiro Furuichi, Chairman of GeneCare Research Institute Co., Ltd., Japan
14:45-15:10	Title:TBD Dr. Alexandra Forsbach, Coley Pharmaceutical GmbH, Germany
15:10-15:30	Coffee Break

Session 4-8: Functional Genomics and Antibody Discovery Time: April 27, 2012, Friday, 13:30-17:10 Place: Xi’ an, China
Chair	Call for Host
Co-Chair	Call for Co-Host
13:30-13:55	Speech Opportunity Available
13:55-14:20	*Title:* Role of Histone Chaperones in AID Induced Antibody Gene Diversification Dr. Nasim Begum, Associate Professor, Department of Immunology & Genomic Medicine, Kyoto University Graduate School of Medicine Konoe-cho, Japan
14:20-14:45	Title: TBD Dr. Gerhard Zugmaier, Professor, Medicine University of Marburg, Germany
14:45-15:10	Title:Targeting the Cemx Segment of Membrane-Bound Ige for Severe Asthma and Allergy Dr. Tse Wen Chang, Distinguished Research Fellow, Genomics Research Center, Academia Sinica, Taiwan
15:10-15:30	Coffee Break

Session 4-9: Functional Genomics and Vaccine Discovery Time: April 28, 2012, Saturday, 08:30- 12:10 Place: Xi‘ an, China
Chair	*Dr.Ioana R. Moldovan*, Associate Director, GLP Laboratory,Cellular Technology Limited, USA
Co-Chair	Call for Co-Host
08:30-08:55	*Speech Opportunity Available*
08:55-09:20	Title: Immunogenicity and Efficacy of a Tetravalent Chimeric Dengue Vaccine (DENVax) in Nonhuman Primates Dr. Ioana R. Moldovan, Associate Director, GLP Laboratory, Cellular Technology Limited, USA
09:20-09:45	Title: TBD Dr. Monica Florin-Christensen, Institute of Pathobiology, Argentina
09:45-10:10	Title: TBD Dr.Varsha Potdar, Scientist, Influenza Group, National institute of Virology, India
10:10-10:30	Coffee Break

Session 4-10: Functional Genomics and Cell Therapy and Gene Therapy Time: April 28, 2012, Saturday, 08:30- 12:10 Place: Xi‘ an, China
Chair	Call for Host
Co-Chair	Call for Co-Host
08:30-08:55	Speech Opportunity Available
08:55-09:20	Title: Treating Blindness by Saving the Cones Dr. Thierry Leveillard, Center Director, Université Pierre et Marie Curie-Paris6, France
09:20-09:45	Title: TBD Dr. Taiyoun Rhim, Professor, Hanyang University, Republic of Korea
09:45-10:10	Title: TBD Dr. Peng Liu, Assistant Professor, University of Michigan, USA
10:10-10:30	Coffee Break

Hosting Organizations

Information Research
Center of International Talent, SAFEA

China Council for the Promotion of
International Trade
Xi'an Sub-Council

China Medical Biotech Associatio

Operating Organization

BIT Congress Inc.
Foreign Experts Databank
of SAFEA-Dalian Biotechnological
and Medical Experts Subdivision

Official Travel Agent

BIT World Travel Service, Inc.